Coronary Artery Disease

38 competing products in clinical development for Coronary Artery Disease.

Pipeline by Phase

Pre-clinical11

Phase 15

Phase 25

Phase 36

Approved11

All Products (38)

Product	Company	Stage	Status	Hype
Clopidogrel treatment group	Yuhan	Approved	Recruiting	50
statins, ezetimibe + Combination therapy	Yuhan	Approved	Recruiting	50
Prasugrel + Clopidogrel	Daiichi Sankyo	Approved	Completed	43
Placebo & Aspirin + Clopidogrel & Aspirin, Prasugrel & Aspirin	Daiichi Sankyo	Approved	Completed	43
Atorvastatin + Niacin + Colesevelam + Placebo Niacin + Placebo Colesevelam	Daiichi Sankyo	Approved	Completed	43
Edoxaban 60 mg + Edoxaban 30 mg + Clopidogrel 75 mg + Aspirin 81 mg	Daiichi Sankyo	Approved	Completed	43
Prasugrel + Clopidogrel	Daiichi Sankyo	Approved	Completed	43
Prasugrel Loading Dose + Prasugrel Maintenance Dose + Ticagrelor Maintenance Dose	Daiichi Sankyo	Approved	Completed	43
Exenatide	Eli Lilly	Phase 3	Completed	40
Sarpogrelate + Aspirin + Clopidogrel + Placebo (for Sarpogrelate)	Yuhan	Phase 3	Completed	40
Regadenoson; Optison	Astellas Pharma	Phase 3	Completed	40
Regadenoson + Adenosine	Astellas Pharma	Phase 3	Completed	40
Regadenoson + Adenosine	Astellas Pharma	Phase 3	Completed	40
ONO-1101 + ONO-1101	Ono Pharmaceutical	Phase 3	Completed	40
regadenoson	Astellas Pharma	Approved	UNKNOWN	39
Rest/Dipyridamole Stress Rb-82 Myocardial Perfusion PET/CT + Rest/Lexiscan(TM) Stress Rb-82 Myocardial Perfusion PET	Astellas Pharma	Approved	UNKNOWN	39
Prasugrel + Clopidogrel + Placebo for Prasugrel + Placebo for Clopidogrel	Daiichi Sankyo	Phase 2	Completed	35
E5555 50 mg + E5555 100 mg + E5555 200 mg + Placebo	Eisai	Phase 2	Completed	35
E5555 + Placebo	Eisai	Phase 2	Completed	35
ONO-1101	Ono Pharmaceutical	Phase 2	Completed	35
ONO-1101 + ONO-1101 + ONO-1101	Ono Pharmaceutical	Phase 2	Completed	35
Evolocumab	HeartFlow	Approved	Withdrawn	29
prasugrel + clopidogrel	Daiichi Sankyo	Phase 1	Completed	29
prasugrel + clopidogrel	Daiichi Sankyo	Phase 1	Completed	29
adenosine + regadenoson	Astellas Pharma	Phase 1	Completed	29
Regadenoson	Astellas Pharma	Phase 1	Completed	29
Rosuvastatin 40mg + Placebo	HeartFlow	Pre-clinical	Recruiting	27
prasugrel + placebo + aspirin	Daiichi Sankyo	Pre-clinical	Completed	26
Regadenoson	Astellas Pharma	Pre-clinical	Completed	26
Regadenoson + Adenosine + N-13 ammonia	Astellas Pharma	Pre-clinical	Completed	26
FFR Measurement with IV Adenoscan® then with Regadenoson	Astellas Pharma	Pre-clinical	Completed	26
regadenoson + Optimark®	Astellas Pharma	Pre-clinical	Completed	26
Caffeine + Caffeine	Astellas Pharma	Pre-clinical	Completed	26
Regadenoson	Astellas Pharma	Pre-clinical	Completed	26
Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere	Astellas Pharma	Pre-clinical	Completed	26
Regadenoson	Astellas Pharma	Pre-clinical	Completed	26
Regadenoson + Dobutamine	Astellas Pharma	Phase 1	Terminated	21
High intensity lipid lowering	HeartFlow	Pre-clinical	Completed	20